Price
Prices are end-of-day closes. This is a research view, the focus is on the fundamentals, quality and valuation below, not intraday price.
Smart Score
AverageTo assure continued alignment with the patients and healthcare community we serve, we have adopted the Quintuple Aim as our “north star.” Starting with a focus on patients, we seek to demonstrate that our products can deliver better outcomes that are validated by rigorous, independent, and peer-reviewed evidence. Second, we aim to create better patient experiences that enable patients to get back to what matters most in their lives more quickly, with fewer complications, less pain and discomfort, and greater predictability.
In the company’s own words · 10-K filed Feb 3, 2026 · SEC EDGAR
Business segments
Q2 2026 · $2.41BThe company’s own SEC segment disclosure.
- Instruments and Accessories$1.18B49%
- Service$472.4M20%
- Systems$442.1M18%
- Services$310.7M13%
Intuitive Surgical (ISRG) reported revenue of $2.89B in Q2 2026 (quarter ended June 30, 2026), up 19% from the same quarter a year earlier. That came with a gross margin of 68% and net income of $818M (28% of revenue). For the full year FY2025, revenue was $10.1B (+21% year on year) and net income $2.86B. Its largest product in 2026-Q2 was Instrumentsand Accessories at $1.18B, 49% of the disclosed total, just ahead of Service at 20%.
Raw charts
10 series · TTMAs reported to the SEC, without any scoring.
Medical Instruments & Supplies
Ranks #16 of 27 by Smart Score